Evidence map›Paper›PMID 39172027›Full record

ArticleAutophagy2025

TRIM21-mediated ubiquitination of SQSTM1/p62 abolishes its Ser403 phosphorylation and enhances palmitic acid cytotoxicity.

Peng Yang, Shenglan Gao, Jianliang Shen, Tong Liu, Kevin Lu, Xinlu Han, Jun Wang, Hong-Min Ni, Wen-Xing Ding, Hong Li and 3 more

Abstract read
In one paragraph

Article in Autophagy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. TRIM21: a multifaceted regulator in cancer.Frontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Peng YangDepartment of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Shenglan GaoDepartment of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Jianliang ShenDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, NJ, USA.
Tong LiuDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers University - New Jersey Medical School, Newark, NJ, USA.
Kevin LuDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, NJ, USA.
Xinlu HanDepartment of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Jun WangDepartment of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, NJ, USA.
Hong-Min NiDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Wen-Xing DingDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Hong LiDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers University - New Jersey Medical School, Newark, NJ, USA.
Ji-An PanThe Center for Infection and Immunity Study and Molecular Cancer Research, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, Guangdong, China.
Kesong PengCenter for Metabolism Research, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang 322000, China.
Wei-Xing ZongDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, NJ, USA.

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PANOS G. GEORGOPOULOS · 1988 to 2026
$47.4M
Rutgers Mass Spectrometry Core for Integrative Neuroscience ResearchP30NS046593 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI LI, HONG, LOBEL, PETER · 2004 to 2018
$9.9M
Protein and redox homeostasis in cancer development and therapyR01CA129536 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI ZONG, WEI-XING · 2008 to 2022
$4.8M
Mechanisms regulating autophagy in alcohol-induced liver injuryR37AA020518 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Wen-Xing Ding · 2019 to 2026
$3.2M
Mechanisms of Impaired Lysosomal Biogenesis and Autophagy in Alcohol-Associated Alzheimer's DiseaseR01AG072895 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING · 2020 to 2024
$1.9M
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolismR01CA232246 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI ZONG, WEI-XING · 2018 to 2022
$1.8M
Mechanisms regulating lipoprotein secretion and lipid metabolismR01DK134737 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Hongmin Ni · 2023 to 2026
$1.5M
Orbitrap Fusion Lumos Tribrid MS System for Proteomics Research at Rutgers Newark CampusS10OD025047 · OD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LI, HONG · 2018 to 2018
$1.1M
NCI NIH HHS R01 CA129536NCI NIH HHS R01 CA232246NIAAA NIH HHS R37 AA020518NIA NIH HHS R01 AG072895NIDDK NIH HHS R01 DK134737NIEHS NIH HHS P30 ES005022NIH HHS S10 OD025047NINDS NIH HHS P30 NS046593
6 · The paper itself

Abstract

Long-chain free fatty acids (FFAs) accumulation and oxidative toxicity is a major cause for several pathological conditions. The mechanisms underlying FFA cytotoxicity remain elusive. Here we show that palmitic acid (PA), the most abundant FFA in the circulation, induces S403 phosphorylation of SQSTM1/p62 (sequestosome 1) and its aggregation, which sequesters KEAP1 and activates the non-canonical SQSTM1-KEAP1-NFE2L2 antioxidant pathway. The PA-induced SQSTM1 S403 phosphorylation and aggregation are dependent on SQSTM1 K7-D69 hydrogen bond formation and dimerization in the Phox and Bem1 (PB1) domain, which facilitates the recruitment of TBK1 that phosphorylates SQSTM1 S403. The ubiquitin E3 ligase TRIM21 ubiquitinates SQSTM1 at the K7 residue and abolishes the PB1 dimerization, S403 phosphorylation, and SQSTM1 aggregation. TRIM21 is oxidized at C92, C111, and C114 to form disulfide bonds that lead to its oligomerization and decreased E3 activity. Mutagenizing the three C residues to S (3CS) abolishes TRIM21 oligomerization and increases its E3 activity. TRIM21 ablation leads to decreased SQSTM1 K7 ubiquitination, hence elevated SQSTM1 S403 phosphorylation and aggregation, which confers protection against PA-induced oxidative stress and cytotoxicity. Therefore, TRIM21 is a negative regulator of SQSTM1 phosphorylation, aggregation, and the antioxidant sequestration function. TRIM21 is oxidized to reduce its E3 activity that helps enhance the SQSTM1-KEAP1-NFE2L2 antioxidant pathway. Inhibition of TRIM21 May be a viable strategy to protect tissues from lipotoxicity resulting from long-chain FFAs.

Indexed as

Kelch-Like ECH-Associated Protein 1Palmitic AcidSequestosome-1 ProteinUbiquitinationAnimalsHEK293 CellsHumansMiceNF-E2-Related Factor 2PhosphorylationRibonucleoproteinsSerineSS-A AntigenKEAP1 protein, humanKeap1 protein, mouseKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Palmitic AcidRibonucleoproteinsSequestosome-1 ProteinSerineSQSTM1 protein, humanSqstm1 protein, mouseSS-A AntigenFree fatty acidsKEAP1lipotoxicityliver damageNFE2L2ROS

Identifiers

PMID39172027
PMCPMC11702951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.